TB 500 10mg

TB 500 10mg – product characteristics

TB 500 10mg is a synthetic research peptide described as a derivative of thymosin beta-4, which belongs to a group of endogenous peptides involved in the regulation of repair processes and cytoskeletal organisation. In the literature, TB 500 is identified as an acetylated fragment of the thymosin beta-4 sequence, described as a Ac-LKKTETQ, which forms the basis of its structural classification as a short peptide with a simplified structure relative to the parent molecule. Thymosin beta-4 itself is described as a peptide containing 43 amino acids and with an important role in interactions with actin, providing an important mechanistic background for analyses on TB-500.

In research, TB 500 is primarily analysed in the context of processes related to healing, cell migration and the organisation of tissue responses to injury. Interest in this peptide stems from the broader literature on thymosin beta-4, which has been linked to cytoskeletal remodelling, regulation of cell movement and promotion of repair processes in various tissue models. In this view, TB-500 remains a research tool for use in analyses involving soft tissues, post-traumatic response and mechanisms related to the restoration of the integrity of biological structures.

The relationship between the activity of thymosin beta-4 derivatives and vascular processes, angiogenesis and tissue regeneration also remains an important area of scientific interest. Publications on Tβ4 have pointed to its association with repair of damaged structures, formation of new vessels and modulation of the cellular environment to promote healing. In parallel, the importance of the actin-binding domain, which is one of the most important functional elements of this group of peptides, is highlighted and explains the interest in shorter fragments, such as TB-500, in experimental models related to tissue regeneration and adaptation.

Also check the peptide reagent TB-500 5 mg 

From a scientific characterisation perspective, the main research advantages of TB 500 10mg include its small molecule size, its simplified structure relative to full thymosin beta-4, and its association with a well-described mechanistic background in the literature concerning actin, cell migration and repair processes. However, the available literature highlights that much of the data relates directly to thymosin beta-4, whereas for TB-500 alone the range of documented studies is clearly narrower, so interpretation of the results should take into account the experimental nature of this molecule and the limitations of the available literature.

Scientific sources:

1. Identification of TB-500 as the N-terminally acetylated 17-23 fragment of thymosin beta-4 (Ac-LKKTETQ).
2. Review on the biological activities of thymosin beta-4, including actin binding, cell migration and active functional domains.
3. Review describing thymosin beta-4 as a multifunctional regenerative peptide associated with tissue repair and cellular reconstruction.
4. A more recent review summarising the involvement of Tβ4 in angiogenesis, tissue repair and regeneration.

The product is intended for scientific research and laboratory analysis. All articles and information on this website are for informational and educational purposes only.